154128-83-3

Basic information

• Product Name: 1H-Isoindole-1,3(2H)-dione, 2-[[4-(phenylmethoxy)phenyl]methyl]-
• CAS NO: 154128-83-3
• Molecular Formula: C22H17NO3
• Molecular Weight: 343.382
• Mol File: 154128-83-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1H-Isoindole-1,3(2H)-dione, 2-[[4-(phenylmethoxy)phenyl]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Isoindole-1,3(2H)-dione, 2-[[4-(phenylmethoxy)phenyl]methyl]-(154128-83-3)
• EPA Substance Registry System: 1H-Isoindole-1,3(2H)-dione, 2-[[4-(phenylmethoxy)phenyl]methyl]-(154128-83-3)

Safety Data

• Hazardous Substances Data: 154128-83-3(Hazardous Substances Data)

Upstream product

• 1074-82-4 potassium phtalimide 
• 836-42-0 4-benzyloxybenzyl chloride 
• 100-44-7 benzyl chloride 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 722537-99-7 1-(azidomethyl)-4-(benzyloxy)benzene 
• 85-44-9 phthalic anhydride 
• 22171-15-9 4-(benzyloxy)benzylamine 
• 123-08-0 4-hydroxy-benzaldehyde 
• 836-43-1 4-benzyloxybenzyl alcohol 

Downstream Products

• 22171-15-9 4-(benzyloxy)benzylamine 
• 24124-24-1 2-(4-Hydroxybenzyl)isoindole-1,3-dione 

Relevant articles and documents

Purinenucleoside derivative modified in 8-position and medical use thereof

The present invention provides an 8-modified purinenucleoside derivative which is useful for diseases associated with an abnormality of plasma uric acid level. An 8-modified purinenucleoside derivative represented by the following formula (I), a prodrug thereof or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof, is useful for the prevention or treatment of gout, hyperuricemia, urinary lithiasis, hyperuricemic nephropathy or the like. In the formula, n is 1 or 2; RA is a hydrogen atom or a hydroxyl group; R1 is a hydrogen atom, a hydroxyl group, a thiol group, an amino group or a chlorine atom; ring J represents an optionally substituted 2-naphthyl group, or a group represented by the following general formula (II) wherein Y represents a single bond or a connecting group; ring Z represents an optionally substituted aryl group or heteroaryl group or the like; and R2 to R4, P1 and Q represents a halogen atom, a cyano group or the like.

NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND

The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula -NH-C(=O)-, a group represented by the formula -C(=O)-NH-, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].